ACADIA PHARMACEUTICALS INC. (ACAD) Debt Components
- 2012-03-31: Long-term Debt, Current MaturitiesUSD $22.00K.
- 2011-12-31: Long-term Debt, Current MaturitiesUSD $32.00K.
- 2011-09-30: Long-term Debt, Current MaturitiesUSD $37.00K.
- 2011-06-30: Long-term Debt, Current MaturitiesUSD $40.00K.
ACADIA PHARMACEUTICALS INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD |
|---|---|
| 2012-03-31 | $22.00K |
| 2011-12-31 | $32.00K |
| 2011-09-30 | $37.00K |
| 2011-06-30 | $40.00K |
| 2010-12-31 | $78.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |